Cargando…

Distinct gene expression profiles associated with the susceptibility of pathogen-specific CD4+ T cells to HIV-1 infection

Detalles Bibliográficos
Autores principales:	Hu, H, Nau, M, Ehrenberg, P, Chenine, A, Daye, Z, Wei, Z, Michael, N, Vahey, M, Kim, J, Marovich, M, Ratto-Kim, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441412/ http://dx.doi.org/10.1186/1742-4690-9-S2-O46

Ejemplares similares

OA04-02. Strong HIV-specific CD4 and CD8 T-lymphocyte proliferation in HIV-1 DNA prime/modified vaccinia virus Ankara (MVA) heterologous boost vaccinees
por: Nilsson, C, et al.
Publicado: (2009)

OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial
por: Currier, JR, et al.
Publicado: (2009)

Antibody-mediated inhibition of HIV-1 elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults
por: Joachim, A, et al.
Publicado: (2012)

Misguiding cues used by HIV to thwart protective immunity
por: Reinherz, EL, et al.
Publicado: (2006)

Identification of CD8+ T cell host factors involved in HIV control
por: Gaiha, G, et al.
Publicado: (2012)

Distinct DC subsets are not equally susceptible to HTLV-1 infection
por: Alais, Sandrine, et al.
Publicado: (2014)

Adenovirus vectors from various serotypes induce distinct cytokine profiles
por: Teigler, JE, et al.
Publicado: (2012)

Cancer susceptibility in ATM heterozygotes: do two distinct carrier populations exist?
por: Gatti, RA, et al.
Publicado: (2000)

S011-05 OA. HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania
por: Koehler, RN, et al.
Publicado: (2009)

S04-04 OA. HIV-specific responses induced by anti-CD40 targeting antibodies
por: Loof, N, et al.
Publicado: (2009)

OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial
por: de Souza, MS, et al.
Publicado: (2009)

Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene
por: O'Connell, RJ, et al.
Publicado: (2012)

Effect of ART on poly functional profile of CD8 responses to Gag and Nef antigen in HIV infected Indian individuals
por: Mendiratta, Sanjay, et al.
Publicado: (2014)

Effect of site-specific de-glycosylation on HIV gp120-specific CD4 T cell responses
por: Li, Hualin, et al.
Publicado: (2006)

Innate immune responses in acute HIV-1 infection: protective or pathogenic?
por: Borrow, Persephone, et al.
Publicado: (2013)

OA031-04. Impairment of HIV-1-specific CD8+ T cell function by soluble epithelial adhesion molecules
por: Streeck, H, et al.
Publicado: (2009)

OA07-02. Adenovirus vectors induce expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1 infection
por: Benlahrech, A, et al.
Publicado: (2009)

CD4-Induced epitopes in HIV infection
por: DeVico, Anthony, et al.
Publicado: (2006)

OA031-02. Regulatory T cells inhibit CD8 T cell proliferation in HIV-1 infection through CD39/adenosine pathway
por: Nikolova, M, et al.
Publicado: (2009)

Changes in CD4+ cells’ miRNA expression following exposure to HIV-1
por: Bignami, F, et al.
Publicado: (2010)

OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial
por: Kim, JH, et al.
Publicado: (2009)

Most HIV DNA in PBMC is present in non-gut homing, resting memory CD4+ T cells with a ß7-CD38-CD127 high phenotype
por: Koelsch, KK, et al.
Publicado: (2010)

0A07-01. HIV-specific CD8(+ )T-cells of vaccinees exhibit proliferative and cytotoxic capacities comparable to those of progressors
por: Rood, JE, et al.
Publicado: (2009)

Restrictions to HIV-1 replication in resting CD4(+) T lymphocytes
por: Fackler, Oliver
Publicado: (2013)

P406 Rise in HIV negative Cryptococcal infection in liver disease patient: epidemiology, risk factor, antifungal susceptibility profile from tertiary care hepatobiliary center
por: Patel, Dhruvi, et al.
Publicado: (2022)

Impact of baseline HIV-1 tropism on viral response and CD4 gains in antiretroviral-naïve patients
por: Seclén, E, et al.
Publicado: (2010)

P036 Epidemiology and antifungal susceptibility profile of infections caused by Fusarium species
por: Capoor, Malini R, et al.
Publicado: (2022)

DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status
por: Flanagan, JM, et al.
Publicado: (2010)

RANKL expression in human T-lymphocytes requires cooperative signaling through the T-cell receptor and adhesion molecule CD2
por: Harvey, B P, et al.
Publicado: (2010)

OA011-01. Early events of human immunodeficiency virus type 1 (HIV-1) ex vivo penetration in the foreskin mimicking HIV-1 sexual transmission
por: Ganor, Y, et al.
Publicado: (2009)

Monoclonal antibodies and small-molecules as distinct subclasses of CCR5-targeted therapies for HIV-1
por: Olson, William C
Publicado: (2006)

Imaging the vessel wall in major peripheral arteries using susceptibility weighted imaging: visualizing calcifications
por: Yang, Qi, et al.
Publicado: (2009)

P398 COVID-19-associated pulmonary aspergillosis: Species distribution and susceptibility profiles
por: Fakhim, Hamed, et al.
Publicado: (2022)

HIV induces the expression of activation-induced cytidine deaminase (AICDA) in B cells through a direct interaction between virion-associated CD40L and CD40
por: Epeldegui, M, et al.
Publicado: (2009)

P042 Identification, clinical profile, antifungal susceptibility pattern of candida auris from a tertiary care center in india
por: Danni, Mary Kiran, et al.
Publicado: (2022)

Distinct DDX DEAD-box RNA helicases cooperate to modulate the HIV-1 Rev and Tat function
por: Ariumi, Yasuo, et al.
Publicado: (2013)

Fatal and non-fatal AIDS and non-AIDS events in HIV-1 infected patients with high CD4 counts
por: Reekie, J, et al.
Publicado: (2010)

HIV-1 antagonism of CD317/tetherin is species-specific and involves Vpu-mediated proteasomal degradation of the intrinsic immunity factor
por: Goffinet, Christine, et al.
Publicado: (2009)

S01-04 OA. Phenotypic analyses of CD8+ T cells that mediate virus inhibition from HIV-1 vaccinees and HIV-1+ virus controllers
por: Freel, SA, et al.
Publicado: (2009)

Detection of broad functional gag-specific CD4+ T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen
por: Ondondo, Beatrice, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_84a36nf19ds0on49lsas7e0tc4